HIV DNA vaccine (Profectus)

N/A

Report date: 2025/10/28 15:11:30

Base Information

Drug NameHIV DNA vaccine (Profectus)

Drug Alias NameHIV MAG DNA vaccine (Profectus Biosciences)adjuvant-enhanced HIV DNA multiepitope-peptide vaccine (Profectus BioSciences)multi-antigen HIV plasmid DNA vaccine (Genevax IL-12 pDNA adjuvant) (Profectus Biosciences)HIV multiantigen DNA vaccine (Profectus Biosciences)

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAfrica

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesWyeth Pharmaceuticals Co

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWyeth Pharmaceuticals Co +[2]

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A